Search

Author/Creator Inose, Ryo

1. A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database. Issue 9 (September 2022)

Authors:
Ito, Saki; Goto, Ryota; Inose, Ryo; Kusama, Yoshiki; Ono, Akane; Koizumi, Ryuji; Ishikane, Masahiro; Ohmagari, Norio; Muraki, Yuichi
Journal:
Journal of infection and chemotherapy
Issue:
Volume 28:Issue 9(2022)
Page Start:
1266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. Issue 7 (July 2021)

Authors:
Mita, Yosuke; Inose, Ryo; Goto, Ryota; Kusama, Yoshiki; Koizumi, Ryuji; Yamasaki, Daisuke; Ishikane, Masahiro; Tanabe, Masaki; Ohmagari, Norio; Muraki, Yuichi
Journal:
Journal of infection and chemotherapy
Issue:
Volume 27:Issue 7(2021)
Page Start:
972
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration. (21st September 2021)

Authors:
Sazanami, Kohei; Inose, Ryo; Dote, Satoshi; Horiuchi, Nozomu; Kobayashi, Yuka; Muraki, Yuichi
Journal:
Journal of chemotherapy
Issue:
Volume 33:Number 6(2021)
Page Start:
440
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Incidence of acute kidney injury after teicoplanin– or vancomycin– and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis. Issue 12 (December 2021)

Authors:
Sazanami, Kohei; Inose, Ryo; Yagi, Tatsuya; Dote, Satoshi; Horiuchi, Nozomu; Kobayashi, Yuka; Muraki, Yuichi
Journal:
Journal of infection and chemotherapy
Issue:
Volume 27:Issue 12(2021)
Page Start:
1723
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Long‐term use of foscarnet is associated with an increased incidence of acute kidney injury in hematopoietic stem cell transplant patients: A retrospective observational study. Issue 2 (10th February 2022)

Authors:
Inose, Ryo; Takahashi, Katsuyuki; Takahashi, Masaya; Sugimoto, Takashi; Nanno, Satoru; Hino, Masayuki; Nagayama, Katsuya
Journal:
Transplant infectious disease
Issue:
Volume 24:Issue 2(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety profile of the concomitant use of foscarnet and aerosolized pentamidine in allogeneic hematopoietic stem cell transplantation recipients. Issue 1 (9th January 2020)

Authors:
Takahashi, Masaya; Takahashi, Katsuyuki; Inose, Ryo; Sugimoto, Takashi; Koh, Hideo; Hino, Masayuki; Nagayama, Katsuya
Journal:
Transplant infectious disease
Issue:
Volume 22:Issue 1(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. Issue 2 (February 2022)

Authors:
Inose, Ryo; Muraki, Yuichi; Kamimoto, Yoko; Kusama, Yoshiki; Koizumi, Ryuji; Yamasaki, Daisuke; Ishikane, Masahiro; Tanabe, Masaki; Ohmagari, Norio
Journal:
Journal of infection and chemotherapy
Issue:
Volume 28:Issue 2(2022)
Page Start:
356
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗